Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN) related to its sale to Servier Pharmaceuticals LLC. Under the terms of the proposed transaction, Day One shareholders are expected to receive $21.50 in cash per share.
Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN) related to its sale to Servier Pharmaceuticals LLC. Under the terms of the proposed transaction, Day One shareholders are expected to receive $21.50 in cash per share.